Circadian peak dopaminergic activity response at the biological clock pacemaker (suprachiasmatic nucleus) area mediates the metabolic responsiveness to a high‐fat diet

Abstract

Among vertebrate species of the major vertebrate classes in the wild, a seasonal rhythm of whole body fuel metabolism, oscillating from a lean to obese condition, is a common biological phenomenon. This annual cycle is driven in part by annual changes in the circadian dopaminergic signalling at the suprachiasmatic nuclei (SCN), with diminution of circadian peak dopaminergic activity at the SCN facilitating development of the seasonal obese insulin-resistant condition. The present study investigated whether such an ancient circadian dopamine-SCN activity system for expression of the seasonal obese, insulin-resistant phenotype may be operative in animals made obese amd insulin resistant by high-fat feeding and, if so, whether reinstatement of the circadian dopaminergic peak at the SCN would be sufficient to reverse the adverse metabolic impact of the high-fat diet without any alteration of caloric intake. First, we identified the supramammillary nucleus as a novel site providing the majority of dopaminergic neuronal input to the SCN. We further identified dopamine D2 receptors within the peri-SCN region as being functional in mediating SCN responsiveness to local dopamine. In lean, insulin-sensitive rats, the peak in the circadian rhythm of dopamine release at the peri-SCN coincided with the daily peak in SCN electrophysiological responsiveness to local dopamine administration. However, in rats made obese and insulin resistant by high-fat diet (HFD) feeding, these coincident circadian peak activities were both markedly attenuated or abolished. Reinstatement of the circadian peak in dopamine level at the peri-SCN by its appropriate circadian-timed daily microinjection to this area (but not outside this circadian time-interval) abrogated the obese, insulin-resistant condition without altering the consumption of the HFD. These findings suggest that the circadian peak of dopaminergic activity at the peri-SCN/SCN is a key modulator of metabolism and the responsiveness to adverse metabolic consequences of HFD consumption. K E Y W O R D Scircadian, diabetes, dopamine, insulin sensitivity, suprachiasmatic nucleiThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Glucose lowering and vascular protective effects of cycloset added to GLP‐1 receptor agonists in patients with type 2 diabetes

“…In addition, our observation that Cycloset therapy was accompanied by a late post‐meal EGP suppression is consistent with a sympatholytic effect, brought about by the use of Cycloset on reducing hepatic glucose production, as shown in animal models . Binding of bromocriptine to D2‐dopamine receptors in hypothalamic centres is known to restrain sympathetic nervous system activity and, act as a sympatholytic agent . As a result, stimulation of hepatic glucose uptake and suppression of glucose production are not surprising.…”

Circadian‐timed quick‐release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus

“…The CNS biological clock circuitry centred on the SCN co‐ordinates autonomic and endocrine system modulation of biochemical metabolic events in the liver, adipose, muscle and other peripheral tissues including the vasculature and heart to generate a whole‐body metabolism and to synchronize/co‐ordinate metabolism within the individual to the cyclic environment (eg, circadian variations in vascular tone and heart rate associated with the sleep/wake cycle, co‐ordination of fuel mobilization with the daily sleep‐fasting period, and anabolic fuel storage processes with wake‐feeding periods of the day). The SCN is the seat of the autonomic nervous system, sending direct and indirect signals to multiple CNS (eg, hypothalamic) centres that are pre‐autonomic fibres regulating sympathetic/parasympathetic activity balance from moment to moment and rhythmically over the course of the day …”

“…The biological clock pacemaker circuit (circadian efferent signals to and including the SCN) for the body is a primary regulator of autonomic balance in the body . A diminution of the circadian peak in dopaminergic input signalling to this SCN clock system (at daily waking from the sleep cycle) is coupled to and potentiates an increase in hypothalamic pre‐autonomic neuronal activities that lead to overactivation of the SNS and metabolic syndrome in animals . The circadian‐timed administration of either dopamine agonist systemically or dopamine to the SCN clock area in insulin‐resistant animals to induce (mimic) the normal circadian peak of dopaminergic activity at the SCN pacemaker that is diminished in insulin resistance states has been observed to reduce chronic overactivity of SNS pre‐autonomic neurons in the hypothalamus and measures of subsequent chronic activation of peripheral sympathetic tone in insulin‐resistant states .…”

Activation of the rat hypothalamic supramammillary nucleus by food anticipation, food restriction or ghrelin administration

“…In addition, c‐Fos expression is increased in the SuM of rats placed in open field apparatus, pointing to a potential role in learning, novelty and/or stress . In the context of circadian behaviours, the rat SuM provides a dopaminergic input into the suprachiasmatic nucleus and dopamine release follows a circadian pattern, with a peak at the onset of the active period of rats . Interestingly, these peaks are attenuated in rats made obese by a high‐fat diet, indicating a potential sensitivity of the SuM to metabolic/nutritional state and/or circulating appetite‐related hormones.…”